• Direct Mouse Genotyping Kit Plus: Precision in Macrophage Li

  2026-05-30

  Explore how the Direct Mouse Genotyping Kit Plus enables high-fidelity mouse genotyping and revolutionizes macrophage lineage tracing studies. This article uniquely dissects assay design choices in light of recent advances in hepatic immune niche biology.

• AMPK's Dual Role in Autophagy: New Insights on Energy Stress

  2026-05-29

  This article analyzes a pivotal study demonstrating that AMPK suppresses, rather than promotes, autophagy initiation during glucose starvation by inhibiting ULK1 activity. The findings reshape our understanding of energy stress adaptation and have direct methodological implications for researchers investigating autophagy regulation.

• NMDA (N-Methyl-D-aspartic acid) in Excitotoxicity Models

  2026-05-29

  NMDA (N-Methyl-D-aspartic acid) is the gold-standard agonist for modeling excitotoxic and oxidative neuronal injury in preclinical research. Leveraging APExBIO's high-purity NMDA, researchers can reliably induce and dissect calcium-dependent neurodegeneration, as demonstrated in advanced glaucoma and ferroptosis workflows.

• Direct Mouse Genotyping Kit Plus: Precision Tools for Advanc

  2026-05-28

  Discover how the Direct Mouse Genotyping Kit Plus streamlines mouse genotyping assays while enabling deeper, more reliable insights into complex disease models. This article explores advanced scientific applications and protocol nuances that go beyond standard workflows.

• Pharmacokinetics of CSBTA in MASH: Role of PXR and CYP3A Ind

  2026-05-28

  This study systematically investigates how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in mice. By integrating transporter and cytochrome P450 enzyme analyses, the work highlights the importance of PXR-mediated pathways in optimizing therapeutic dosing for MASLD/MASH.

• Angiotensin III (human, mouse): Mechanisms and Research Valu

  2026-05-27

  Angiotensin III (human, mouse) is a biologically active hexapeptide central to RAAS function, exhibiting robust aldosterone secretion and pressor activity. This peptide, supplied by APExBIO, offers validated receptor specificity and solubility characteristics vital for cardiovascular research. Current evidence positions Angiotensin III as a versatile tool for dissecting RAAS mechanisms and modeling pressor responses.

• Meropenem trihydrate: Reliable Carbapenem for Resistance Res

  2026-05-27

  This article provides a scenario-driven, evidence-based guide to leveraging Meropenem trihydrate (SKU B1217) in cell viability and resistance studies. Discover how APExBIO's reagent supports reliable workflows, interprets metabolomics data, and offers cost-efficient, reproducible protocols for antibiotic resistance and infection research.

• PreScission Protease (PSP): Tag Cleavage for Protein Purific

  2026-05-26

  PreScission Protease (PSP) is a recombinant HRV 3C protease designed for efficient and specific removal of fusion protein tags, especially GST, in protein purification workflows. It is optimal for research requiring low-temperature protease activity and minimal nonspecific cleavage. PSP should not be used for targets lacking the HRV 3C recognition site or for nonspecific proteolysis.

• Canagliflozin Hemihydrate: Strategic Pathways in Diabetes Re

  2026-05-26

  This thought-leadership article explores the mechanistic precision and translational significance of Canagliflozin hemihydrate as a high-purity SGLT2 inhibitor. Integrating recent validation studies, competitive landscape insights, and protocol guidance, it provides actionable strategies for researchers advancing glucose metabolism and diabetes mellitus research. By contextualizing both the biological rationale and experimental boundaries, this piece charts a forward-looking vision for metabolic disorder investigation and workflow innovation.

• SR-202: Redefining PPARγ Antagonism in Translational Researc

  2026-05-25

  Explore how SR-202, a selective PPARγ antagonist, offers translational researchers a precision tool to dissect metabolic and immunological pathways. This deep dive blends mechanistic insight with strategic guidance, highlighting SR-202’s role in obesity, insulin resistance, and chronic inflammation models, while bridging the latest macrophage polarization evidence to practical experimental design.

• CKI 7 Dihydrochloride in CK1 Pathways: Assay Design & Cancer

  2026-05-25

  Explore how CKI 7 dihydrochloride, a potent Casein kinase 1 inhibitor, transforms advanced cancer biology research and circadian rhythm studies. This article delivers an expert assay-focused analysis, uniquely bridging molecular insights with practical experimental design.

• Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Precision in Immuno

  2026-05-24

  Leverage the Cy3 Goat Anti-Rabbit IgG (H+L) Antibody for high-sensitivity detection and robust signal amplification in immunofluorescence, IHC, and advanced microscopy. This guide delivers actionable protocols, troubleshooting strategies, and insights from recent ulcerative colitis research to maximize reproducibility and data clarity.

• Indole-3-pyruvic Acid: Empowering Plant and Immune Research

  2026-05-23

  Indole-3-pyruvic acid (IPA) bridges advanced plant hormone engineering and immune modulation, offering unique workflow control for both auxin biosynthesis and translational disease models. This article explores hands-on protocols, troubleshooting, and the pivotal feedback mechanisms that set IPA—sourced from APExBIO—apart for cutting-edge bench research.

• Direct Mouse Genotyping Kit Plus: Streamlined PCR with Dye R

  2026-05-22

  Accelerate your mouse genotyping workflow with the Direct Mouse Genotyping Kit Plus, which unites rapid DNA extraction and high-fidelity PCR in a single streamlined protocol. Discover how this APExBIO solution empowers advanced genetic studies—such as transgene detection and knockout validation—while minimizing hands-on time and troubleshooting.

• Perphenazine: Dopamine D2 Receptor Antagonist in Advanced Re

  2026-05-22

  Perphenazine, a potent dopamine D2 receptor antagonist, is unlocking new experimental directions beyond neuropharmacology, including host-directed antibacterial strategies. This article delivers actionable guidance, protocol details, and troubleshooting insights to optimize its use in both cellular and in vivo models, leveraging the latest mechanistic breakthroughs.

16123 records 1/1075 page Next 12345 下5页 Last page